Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Morio Aihara"'
Autor:
Yuki Watanabe, Morio Aihara, Kazuhiro Ooi, Hidehisa Matsumura, Shinpei Matsuda, Hidemichi Yuasa, Yoshizo Matsuka
Publikováno v:
BMJ Open, Vol 12, Iss 8 (2022)
Objectives Therapy outcome measures (TOMs) in temporomandibular disorders (TMDs) have not been systematically evaluated. We systematically explored the main TOM assessment methods for TMD TOMs used in previous studies.Design Scoping review.Data sourc
Externí odkaz:
https://doaj.org/article/0afbe64e42e84052bc2c644ebc4f8858
Autor:
Kazuma Yamakawa, Ryo Yamamoto, Takero Terayama, Hideki Hashimoto, Tadashi Ishihara, Go Ishimaru, Haruki Imura, Hiromu Okano, Chihiro Narita, Takuya Mayumi, Hideto Yasuda, Kohei Yamada, Hiroyuki Yamada, Tatsuya Kawasaki, Nobuaki Shime, Kent Doi, Moritoki Egi, Hiroshi Ogura, Morio Aihara, Shigeki Kushimoto, Osamu Nishida, Special Committee of the Japanese Clinical Practice Guidelines for the Management of Sepsis and Septic Shock 2020 (J‐SSCG 2020), the COVID‐19 Task Force
Publikováno v:
Acute Medicine & Surgery, Vol 9, Iss 1, Pp n/a-n/a (2022)
Background Coronavirus disease (COVID‐19), an infectious disease caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has spread worldwide since early 2020, and there are still no signs of resolution. Th
Externí odkaz:
https://doaj.org/article/29e2b26dcc984e3dbd280625774423f2
Publikováno v:
Journal of Intensive Care, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background Early and accurate diagnosis of sepsis is challenging. Although procalcitonin and presepsin have been identified as potential biomarkers to differentiate between sepsis and other non-infectious causes of systemic inflammation, the
Externí odkaz:
https://doaj.org/article/a9e35536839d4571b9cfc16bcd96bb0d
Autor:
Kazuma Yamakawa, Ryo Yamamoto, Go Ishimaru, Hideki Hashimoto, Takero Terayama, Yoshitaka Hara, Daisuke Hasegawa, Tadashi Ishihara, Haruki Imura, Hiromu Okano, Chihiro Narita, Takuya Mayumi, Hideto Yasuda, Kohei Yamada, Hiroyuki Yamada, Tatsuya Kawasaki, Nobuaki Shime, Kent Doi, Moritoki Egi, Hiroshi Ogura, Morio Aihara, Hiroshi Tanaka, Osamu Nishida, the Special Committee of the Japanese Clinical Practice Guidelines for the Management of Sepsis and Septic Shock 2020 (J‐SSCG 2020), the COVID‐19 Task Force
Publikováno v:
Acute Medicine & Surgery, Vol 8, Iss 1, Pp n/a-n/a (2021)
The coronavirus disease (COVID‐19) has spread worldwide since early 2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines for the Management of Sepsis and Septic Shock (J‐SSCG) 2020 Special Committee created
Externí odkaz:
https://doaj.org/article/11e1cce46ab84eb191ce22b2eed691ea
Autor:
Kazuhiro Ooi, Morio Aihara, Hidehisa Matsumura, Shinpei Matsuda, Yuki Watanabe, Hidemichi Yuasa, Yoshizo Matsuka
Publikováno v:
BMJ open. 12(8)
ObjectivesTherapy outcome measures (TOMs) in temporomandibular disorders (TMDs) have not been systematically evaluated. We systematically explored the main TOM assessment methods for TMD TOMs used in previous studies.DesignScoping review.Data sources
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d7cd1f0e5bfa8afe5474ef1227696d0
https://pubmed.ncbi.nlm.nih.gov/35985779
https://pubmed.ncbi.nlm.nih.gov/35985779
Publikováno v:
Thrombosis and Haemostasis. 119:056-065
Background Clinical effectiveness of recombinant human soluble thrombomodulin (rhTM) in sepsis or sepsis-induced coagulopathy remains a matter of dispute. Recently, the Sepsis Coagulopathy Asahi Recombinant LE Thrombomodulin (SCARLET) trial, the late
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96f12549ac91f8cbf59dd308983692b7
https://doi.org/10.1055/s-0038-1676345
https://doi.org/10.1055/s-0038-1676345
Publikováno v:
Surgical Infections. 18:225-233
To evaluate the efficacy and safety of direct hemoperfusion with polymyxin B-immobilized fiber (PMX-DHP) therapy in patients with sepsis.A systematic review and meta-analysis of four major databases: Cochrane Central Register of Controlled Trials, ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2caa1418174925d48ec376eb44f3972d
https://doi.org/10.1089/sur.2016.168
https://doi.org/10.1089/sur.2016.168
Publikováno v:
BMJ Open
Introduction Early diagnosis and immediate therapeutic intervention, including appropriate antibiotic therapy and goal-directed resuscitation, are necessary to reduce mortality in patients with sepsis. However, a single clinical or biological marker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a61b662be6780c42fbf0f59072970498
http://europepmc.org/articles/PMC5353338
http://europepmc.org/articles/PMC5353338
Publikováno v:
Thrombosis & Haemostasis; 2019, Vol. 119 Issue 1, p56-65, 10p
Autor:
Minoru Inagaki, Masayoshi Negishi, Kaneo Yamada, Yasuharu Nishida, Noboru Takata, Kaoru Shimada, Junichi Mimaya, Satoshi Kimura, Kazuo Mori, Katsuyuki Fukutake, Junki Takamatsu, Morio Aihara
Publikováno v:
Clinical and Diagnostic Virology. 1:245-256
Forty-three hemophiliacs with AIDS or ARC received a daily dose of 334 or 500 mg didanosine (2',3'-dideoxyinosine or ddI) orally in 2 divided doses in phase I/II, open-label clinical trial conducted in Japan. Twenty-eight patients completed 6 months
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e4675ac8c44a0ca6efeafed72c81e24
https://doi.org/10.1016/0928-0197(93)90006-q
https://doi.org/10.1016/0928-0197(93)90006-q